BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 22122050)

  • 1. Role of epigenetics in Alzheimer's and Parkinson's disease.
    Kwok JB
    Epigenomics; 2010 Oct; 2(5):671-82. PubMed ID: 22122050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms in Parkinson's disease.
    Feng Y; Jankovic J; Wu YC
    J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in Parkinson's and Alzheimer's diseases.
    Marques S; Outeiro TF
    Subcell Biochem; 2013; 61():507-25. PubMed ID: 23150265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
    Iraola-Guzmán S; Estivill X; Rabionet R
    Clin Genet; 2011 Jul; 80(1):1-14. PubMed ID: 21542837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease.
    Nicolia V; Lucarelli M; Fuso A
    Exp Gerontol; 2015 Aug; 68():8-12. PubMed ID: 25456841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in Parkinson's Disease.
    Pavlou MAS; Outeiro TF
    Adv Exp Med Biol; 2017; 978():363-390. PubMed ID: 28523556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental-induced oxidative stress in neurodegenerative disorders and aging.
    Migliore L; Coppedè F
    Mutat Res; 2009 Mar; 674(1-2):73-84. PubMed ID: 18952194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in neurodegeneration: a new layer of complexity.
    Marques SC; Oliveira CR; Pereira CM; Outeiro TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):348-55. PubMed ID: 20736041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic programming of neurodegenerative diseases by an adverse environment.
    Babenko O; Kovalchuk I; Metz GA
    Brain Res; 2012 Mar; 1444():96-111. PubMed ID: 22330722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: the quest to understand complexity.
    Marques SC; Oliveira CR; Outeiro TF; Pereira CM
    J Alzheimers Dis; 2010; 21(2):373-83. PubMed ID: 20555132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in Parkinson's disease.
    Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
    J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetically regulated microRNAs in Alzheimer's disease.
    Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
    Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation in Parkinson's disease.
    Labbé C; Lorenzo-Betancor O; Ross OA
    Acta Neuropathol; 2016 Oct; 132(4):515-30. PubMed ID: 27358065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases.
    Migliore L; Coppedè F
    Mutat Res; 2009 Jul; 667(1-2):82-97. PubMed ID: 19026668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies.
    Renani PG; Taheri F; Rostami D; Farahani N; Abdolkarimi H; Abdollahi E; Taghizadeh E; Gheibi Hayat SM
    J Cell Physiol; 2019 Nov; 234(11):19307-19319. PubMed ID: 30968426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and the neurodegenerative process.
    Słowikowski B; Owecki W; Jeske J; Jezierski M; Draguła M; Goutor U; Jagodziński PP; Kozubski W; Dorszewska J
    Epigenomics; 2024 Apr; 16(7):473-491. PubMed ID: 38511224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.
    Roubroeks JAY; Smith RG; van den Hove DLA; Lunnon K
    J Neurochem; 2017 Oct; 143(2):158-170. PubMed ID: 28805248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.